Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend

Bulletin Express

04/14

Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.

The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1108089810"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108089810\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108089810?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108089810","market":"us","top_or_hot":-1,"title":"Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend","media":"Bulletin Express","content":"<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.</p>\n<p>The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-14 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.</p>\n<p>The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01858","symbol_name":"春立医疗","start_time":0,"source_url":"","article_id":"1108089810","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108089810","pubTimestamp":1776157413,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01858":"春立医疗"},"translate_title":"春立医疗定于2026年4月29日召开董事会批准第一季度业绩并讨论中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01858":1},"content_text":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.\nThe notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}